Kangmei Pharma | 600518 - Gross Profit On Sales



Kangmei Pharma reported CNY193.92M in Gross Profit on Sales for its fiscal quarter ending in September of 2024.

Gross Profit On Sales Change Date
Alaunos Therapeutics -1127000 1.11M Sep/2024
Avita Medical AUD 13.08M 3.49M Jun/2024
Cspc Pharmaceutical CNY 5.16B 1.34B Jun/2024
Genomma Lab Internacional MXN 3.27B 294.3M Sep/2024
Hypermarcas BRL 1.33B 218.22M Jun/2024
Ionis Pharmaceuticals USD -140480000 139.48M Sep/2024
IQVIA Holdings USD 915M 411M Sep/2024
Jiangsu Hengrui CNY 5.61B 1.06B Sep/2024
Kangmei Pharma CNY 193.92M 20.58M Sep/2024
Moderna USD 13M 113M Sep/2024
Organon & Co USD 939M 18M Jun/2024
Revvity USD 384.82M 690K Sep/2024
Sh Fosun Pharma CNY 5.04B 201.71M Sep/2024
Viatris USD 1.46B 13.8M Sep/2024
Wuxi Apptec CNY 3.04B 1.25B Mar/2024
Xeris Pharmaceuticals USD 40.28M 5.61M Jun/2024
Zz Pientze Pharmaceu 1.02B 475.57M Jun/2024